Cell surface-binding motifs of L2 that facilitate papillomavirus infection

Rongcun Yang, Patricia M. Day, William H. Yutzy IV, Ken Yu Lin, Chien Fu Hung, Richard B S Roden

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Human papillomavirus type 16 (HPV16) is the primary etiologic agent of cervical carcinoma, whereas bovine papillomavirus type 1 (BPV1) causes benign fibropapillomas. However, the capsid proteins, L1 and L2, of these divergent papillomaviruses exhibit functional conservation. A peptide comprising residues 1 to 88 of BPV1 L2 binds to a variety of cell lines, but not to the monocyte-derived cell line D32, and blocks BPV1 infection of mouse C127 cells. Residues 13 to 31 of HPV16 L2 and BPV1 L2 residues 1 to 88 compete for binding to the cell surface, and their binding, unlike that of HPV16 L1/L2 virus-like particles, is unaffected by heparinase or trypsin pretreatment of HeLa cells. A fusion of HPV16 L2 peptide 13-31 and GFP binds (Kd, ∼1 nM) to ∼45,000 receptors per HeLa cell. Furthermore, mutation of L2 residues 18 and 19 or 21 and 22 significantly reduces both the ability of the HPV16 L2 13-31-GFP fusion protein to bind to SiHa cells and the infectivity of HPV16 pseudovirions. Antibody to BPV1 L2 peptides comprising residues 115 to 135 binds to intact BPV1 virions, but fails to neutralize at a 1:10 dilution. However, deletion of residues 91 to 129 from L2 abolishes the infectivity of BPV1, but not their binding to the cell surface. In summary, L2 residues 91 to 129 contain epitopes displayed on the virion surface and are required for infection, but not virion binding to the cell surface. Upon the binding of papillomavirus to the cell surface, residues 13 to 31 of L2 interact with a widely expressed, trypsin- and heparinase-resistant cell surface molecule and facilitate infection.

Original languageEnglish (US)
Pages (from-to)3531-3541
Number of pages11
JournalJournal of Virology
Volume77
Issue number6
DOIs
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Bovine papillomavirus 1
Papillomavirus Infections
Papillomaviridae
Human papillomavirus 16
Virion
infection
Heparin Lyase
cells
virion
HeLa Cells
Trypsin
Peptides
peptides
trypsin
Cell Line
pathogenicity
cell lines
Capsid Proteins
Infection
uterine cervical neoplasms

ASJC Scopus subject areas

  • Immunology

Cite this

Cell surface-binding motifs of L2 that facilitate papillomavirus infection. / Yang, Rongcun; Day, Patricia M.; Yutzy IV, William H.; Lin, Ken Yu; Hung, Chien Fu; Roden, Richard B S.

In: Journal of Virology, Vol. 77, No. 6, 01.03.2003, p. 3531-3541.

Research output: Contribution to journalArticle

Yang, Rongcun ; Day, Patricia M. ; Yutzy IV, William H. ; Lin, Ken Yu ; Hung, Chien Fu ; Roden, Richard B S. / Cell surface-binding motifs of L2 that facilitate papillomavirus infection. In: Journal of Virology. 2003 ; Vol. 77, No. 6. pp. 3531-3541.
@article{f60c387580b84f1394324e36f0271cf3,
title = "Cell surface-binding motifs of L2 that facilitate papillomavirus infection",
abstract = "Human papillomavirus type 16 (HPV16) is the primary etiologic agent of cervical carcinoma, whereas bovine papillomavirus type 1 (BPV1) causes benign fibropapillomas. However, the capsid proteins, L1 and L2, of these divergent papillomaviruses exhibit functional conservation. A peptide comprising residues 1 to 88 of BPV1 L2 binds to a variety of cell lines, but not to the monocyte-derived cell line D32, and blocks BPV1 infection of mouse C127 cells. Residues 13 to 31 of HPV16 L2 and BPV1 L2 residues 1 to 88 compete for binding to the cell surface, and their binding, unlike that of HPV16 L1/L2 virus-like particles, is unaffected by heparinase or trypsin pretreatment of HeLa cells. A fusion of HPV16 L2 peptide 13-31 and GFP binds (Kd, ∼1 nM) to ∼45,000 receptors per HeLa cell. Furthermore, mutation of L2 residues 18 and 19 or 21 and 22 significantly reduces both the ability of the HPV16 L2 13-31-GFP fusion protein to bind to SiHa cells and the infectivity of HPV16 pseudovirions. Antibody to BPV1 L2 peptides comprising residues 115 to 135 binds to intact BPV1 virions, but fails to neutralize at a 1:10 dilution. However, deletion of residues 91 to 129 from L2 abolishes the infectivity of BPV1, but not their binding to the cell surface. In summary, L2 residues 91 to 129 contain epitopes displayed on the virion surface and are required for infection, but not virion binding to the cell surface. Upon the binding of papillomavirus to the cell surface, residues 13 to 31 of L2 interact with a widely expressed, trypsin- and heparinase-resistant cell surface molecule and facilitate infection.",
author = "Rongcun Yang and Day, {Patricia M.} and {Yutzy IV}, {William H.} and Lin, {Ken Yu} and Hung, {Chien Fu} and Roden, {Richard B S}",
year = "2003",
month = "3",
day = "1",
doi = "10.1128/JVI.77.6.3531-3541.2003",
language = "English (US)",
volume = "77",
pages = "3531--3541",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Cell surface-binding motifs of L2 that facilitate papillomavirus infection

AU - Yang, Rongcun

AU - Day, Patricia M.

AU - Yutzy IV, William H.

AU - Lin, Ken Yu

AU - Hung, Chien Fu

AU - Roden, Richard B S

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Human papillomavirus type 16 (HPV16) is the primary etiologic agent of cervical carcinoma, whereas bovine papillomavirus type 1 (BPV1) causes benign fibropapillomas. However, the capsid proteins, L1 and L2, of these divergent papillomaviruses exhibit functional conservation. A peptide comprising residues 1 to 88 of BPV1 L2 binds to a variety of cell lines, but not to the monocyte-derived cell line D32, and blocks BPV1 infection of mouse C127 cells. Residues 13 to 31 of HPV16 L2 and BPV1 L2 residues 1 to 88 compete for binding to the cell surface, and their binding, unlike that of HPV16 L1/L2 virus-like particles, is unaffected by heparinase or trypsin pretreatment of HeLa cells. A fusion of HPV16 L2 peptide 13-31 and GFP binds (Kd, ∼1 nM) to ∼45,000 receptors per HeLa cell. Furthermore, mutation of L2 residues 18 and 19 or 21 and 22 significantly reduces both the ability of the HPV16 L2 13-31-GFP fusion protein to bind to SiHa cells and the infectivity of HPV16 pseudovirions. Antibody to BPV1 L2 peptides comprising residues 115 to 135 binds to intact BPV1 virions, but fails to neutralize at a 1:10 dilution. However, deletion of residues 91 to 129 from L2 abolishes the infectivity of BPV1, but not their binding to the cell surface. In summary, L2 residues 91 to 129 contain epitopes displayed on the virion surface and are required for infection, but not virion binding to the cell surface. Upon the binding of papillomavirus to the cell surface, residues 13 to 31 of L2 interact with a widely expressed, trypsin- and heparinase-resistant cell surface molecule and facilitate infection.

AB - Human papillomavirus type 16 (HPV16) is the primary etiologic agent of cervical carcinoma, whereas bovine papillomavirus type 1 (BPV1) causes benign fibropapillomas. However, the capsid proteins, L1 and L2, of these divergent papillomaviruses exhibit functional conservation. A peptide comprising residues 1 to 88 of BPV1 L2 binds to a variety of cell lines, but not to the monocyte-derived cell line D32, and blocks BPV1 infection of mouse C127 cells. Residues 13 to 31 of HPV16 L2 and BPV1 L2 residues 1 to 88 compete for binding to the cell surface, and their binding, unlike that of HPV16 L1/L2 virus-like particles, is unaffected by heparinase or trypsin pretreatment of HeLa cells. A fusion of HPV16 L2 peptide 13-31 and GFP binds (Kd, ∼1 nM) to ∼45,000 receptors per HeLa cell. Furthermore, mutation of L2 residues 18 and 19 or 21 and 22 significantly reduces both the ability of the HPV16 L2 13-31-GFP fusion protein to bind to SiHa cells and the infectivity of HPV16 pseudovirions. Antibody to BPV1 L2 peptides comprising residues 115 to 135 binds to intact BPV1 virions, but fails to neutralize at a 1:10 dilution. However, deletion of residues 91 to 129 from L2 abolishes the infectivity of BPV1, but not their binding to the cell surface. In summary, L2 residues 91 to 129 contain epitopes displayed on the virion surface and are required for infection, but not virion binding to the cell surface. Upon the binding of papillomavirus to the cell surface, residues 13 to 31 of L2 interact with a widely expressed, trypsin- and heparinase-resistant cell surface molecule and facilitate infection.

UR - http://www.scopus.com/inward/record.url?scp=0037333367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037333367&partnerID=8YFLogxK

U2 - 10.1128/JVI.77.6.3531-3541.2003

DO - 10.1128/JVI.77.6.3531-3541.2003

M3 - Article

C2 - 12610128

AN - SCOPUS:0037333367

VL - 77

SP - 3531

EP - 3541

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 6

ER -